S100A9 and Alzheimer disease: S100A9 was found to be strongly increased in brain lysates of AD patients and AD mice compared to healthy, age-matched controls (Ha et al., 2010; Chang et al., 2012; Kummer et al., 2012) and in familial PS-1 AD tissues (Shepherd et al., 2006).